Cypress Bioscience Chairman/CEO to Interview On RadioWallStreet Internet Broadcast
Business Wire - August 06, 1999 07:15
PHILADELPHIA--(BUSINESS WIRE)--Aug. 6, 1999--Cypress Bioscience Inc. (NASDAQ:CYPB) Chairman/CEO Jay D. Kranzler M.D., Ph.D. will be interviewed on RadioWallStreet Friday, August 6, 1999, at 1:00 PM EDT, Investor Broadcast Network f/k/a Vcall Corporation announced.
Dr. Kranzler will discuss current news, his product the PROSORBA(R) column (the first FDA approved non-drug treatment for rheumatoid arthritis), as well as the dynamics of his business and the biotechnology industry. Conducting the interview for RadioWallStreet will be Eric Sichel M.D. of Emerald Research, a leading equity research firm.
To listen to the interview, investors should go to the RadioWallStreet website located at vcall.com and click on the RadioWallStreet event.
RadioWallStreet is an Investor Broadcast Network service that broadcasts senior executive interviews, analyst roundtable discussions, seminars and other events of interest to the investment community. RadioWallStreet events are open to the investing public and may be heard over the Internet.
Questions for this RadioWallStreet event may be submitted in advance by e-mailing greg@vcall.com. Please reference date and time in the Subject of the e-mail.
CONTACT: Investor Broadcast Network
Greg Kettler, 717/396-1116 x304
TICKERS: NASDAQ:CYPB
|
